SCHEMBL22563431

SCHEMBL22563431

N#Cc1cc(-n2c3ccc(C#N)cc3c3cc(C#N)ccc32)c(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)c(-n2c3ccc(C#N)cc3c3cc(C#N)ccc32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.44
ABCB1 P08183 3/20 0.43
KDM4E B2RXH2 3/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CSF1R P07333 2/20 0.40
JAK2 O60674 1/20 0.40
PRKD3 O94806 1/20 0.40
ABL1 P00519 1/20 0.40
EGFR P00533 1/20 0.40
ERBB2 P04626 1/20 0.40
LCK P06239 1/20 0.40
CDK1 P06493 1/20 0.40
LYN P07948 1/20 0.40
RET P07949 1/20 0.40
KIT P10721 1/20 0.40
FGFR1 P11362 1/20 0.40
FER P16591 1/20 0.40
FLT1 P17948 1/20 0.40
FGFR3 P22607 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22563499 0.96 ABCG2 (0.43) ABCG2ABCB1KDM4ELMNASMN1; SMN2
SCHEMBL21279070 0.93 ABCG2 (0.45) ABCG2ABCB1KDM4ELMNASMN1; SMN2
SCHEMBL22563562 0.93 MYC (0.44) ABCG2ABCB1KDM4ELMNASMN1; SMN2
SCHEMBL22563571 0.91 MYC (0.42) ABCG2ABCB1KDM4ELMNASMN1; SMN2
SCHEMBL21108007 0.91 ABCG2 (0.45) ABCG2ABCB1KDM4ELMNACLK4
SCHEMBL19909191 0.90 MYC (0.43) ABCG2ABCB1KDM4ELMNASMN1; SMN2
SCHEMBL21279102 0.90 ABCG2 (0.43) ABCG2ABCB1KDM4ELMNASMN1; SMN2
SCHEMBL22563555 0.90 ABCG2 (0.41) ABCG2ABCB1KDM4ELMNASMN1; SMN2
SCHEMBL23487339 0.89 ABCG2 (0.44) ABCG2ABCB1KDM4ELMNASMN1; SMN2
SCHEMBL23487715 0.89 KDM4E (0.39) ABCG2ABCB1KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 US disclosed
EP-3580300-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 ABCG2 2612/4885ABCB1 1179/4885KDM4E 4619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.